Especially, Cldn-4 is highly expressed in both primary and metastatic prostate cancer suggesting a potential role of Cldn-4 as a prognostic factor for advanced and metastatic prostate cancer (253, 254). Here, CLDN4 is linked to metastatic prostate carcinoma.